Screening ultrasounds plus mammography may find more cancers in women who have breast dense tissue.
Editor's Note: An earlier version of this article stated that ultrasound screening for women with dense breasts results in fewer false positives. However, screening ultrasound increases the number of false positive biopsies. The article has been corrected.
Ultrasound screening for women with dense breasts detects a small number of additional cancers, compared to screening mammography alone, at the expense of a significant number of additional false positive biopsies, according to an article published in the American Journal of Obstetrics & Gynecology.
Researchers from the University of Washington in Seattle performed a comprehensive literature review of studies regarding breast cancer screening of women with dense breast tissue in the United States published from January 2000 and April 2013. Of 189 peer-reviewed publications, the researchers found 12 studies that fit their criteria.
[[{"type":"media","view_mode":"media_crop","fid":"25562","attributes":{"alt":"ultrasound","class":"media-image media-image-right","id":"media_crop_9441809144336","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2340","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 134px; width: 200px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image"}}]]
The findings showed that when ultrasound was used in addition to mammography, physicians found an additional 0.3 to 7.7 cancers per 1,000 examinations (median 4.2) than when mammography was performed alone. There were also an additional 11.7 to 106.6 biopsies per 1,000 examinations (median 52.2).
“Most of the breast cancers identified by adjunctive US were small in size and node-negative in stage,” the authors wrote. “These are the cancers that are potentially curable by early detection and amenable to less aggressive treatment.” The researchers did point out, however, that some of the earlier staged cancers may have remained stable and been detected during the next regular screening mammography.
The researchers concluded that physicians should discuss with their patients how dense breast tissue can be a risk factor for breast cancer and whether the use of adjunctive screening, such as ultrasound, in addition to mammography screening may be beneficial for the patient.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer
January 3rd 2025Adjunctive AI offered greater than seven percent increases in sensitivity, specificity, and accuracy for ultrasound detection of ovarian cancer in comparison to unassisted clinicians who lacked ultrasound expertise, according to findings from new international multicenter research.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.